[
  {
    "ts": "2025-11-23T12:01:58+00:00",
    "headline": "Analysts Shift to Hold as Cidara’s (CDTX) Recent Acquisition Deal Caps Upside",
    "summary": "Cidara Therapeutics Inc. (NASDAQ:CDTX) is the top stock in our list of the hottest SMID-cap stocks so far in 2025 with a 717% share price surge year-to-date. Following the acquisition announcement by Merck & Co. Inc. (NYSE:MRK), Guggenheim analyst Seamus Fernandez downgraded his rating on Cidara Therapeutics from Buy to Neutral on November 17, according to […]",
    "url": "https://finance.yahoo.com/news/analysts-shift-hold-cidara-cdtx-120158103.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "5d2520ff-2ea5-33d3-94b0-9c3c1adadabb",
      "content": {
        "id": "5d2520ff-2ea5-33d3-94b0-9c3c1adadabb",
        "contentType": "STORY",
        "title": "Analysts Shift to Hold as Cidara’s (CDTX) Recent Acquisition Deal Caps Upside",
        "description": "",
        "summary": "Cidara Therapeutics Inc. (NASDAQ:CDTX) is the top stock in our list of the hottest SMID-cap stocks so far in 2025 with a 717% share price surge year-to-date. Following the acquisition announcement by Merck & Co. Inc. (NYSE:MRK), Guggenheim analyst Seamus Fernandez downgraded his rating on Cidara Therapeutics from Buy to Neutral on November 17, according to […]",
        "pubDate": "2025-11-23T12:01:58Z",
        "displayTime": "2025-11-23T12:01:58Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/86e6e9c894c54777e4f717e67f1c36b3",
          "originalWidth": 1000,
          "originalHeight": 681,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xFBTrAHbjCbg1tTtkCV2fg--~B/aD02ODE7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/86e6e9c894c54777e4f717e67f1c36b3.cf.webp",
              "width": 1000,
              "height": 681,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/CBDWEfmuT6zO0KcotxAG5w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/86e6e9c894c54777e4f717e67f1c36b3.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/analysts-shift-hold-cidara-cdtx-120158103.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/analysts-shift-hold-cidara-cdtx-120158103.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CDTX"
            },
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]